Skip to main content

CORRECTION article

Front. Pharmacol., 16 June 2022
Sec. Ethnopharmacology

Corrigendum: Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis

Lingli DingLingli Ding1Song GuSong Gu2Bingyu ZhouBingyu Zhou1Min WangMin Wang1Yage ZhangYage Zhang1Siluo WuSiluo Wu1Hong ZouHong Zou3Guoping Zhao,,,,,
Guoping Zhao4,5,6,7,8,9*Zhao Gao
Zhao Gao10*Liangliang Xu
Liangliang Xu1*
  • 1Key Laboratory of Orthopaedics and Traumatology, Lingnan Medical Research Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
  • 2The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, China
  • 3Engineering Laboratory for Nutrition, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China
  • 4Master Lab for Innovative Application of Nature Products, National Center of Technology Innovation for Synthetic Biology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China
  • 5CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
  • 6CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China
  • 7Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China
  • 8State Key Laboratory of Genetic Engineering, Department of Microbiology and Immunology, School of Life Sciences, Fudan University, Shanghai, China
  • 9Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China
  • 10Er Sha Sports Training Center of Guangdong Province, Guangzhou, China

A Corrigendum on
Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis

by Ding L, Gu S, Zhou B, Wang M, Zhang Y, Wu S, Zou H, Zhao G, Gao Z and Xu L (2022). Front. Pharmacol. 13:855393. doi: 10.3389/fphar.2022.855393

In the original article, there was a mistake in Figure 3A as published. Figure 3A is a schematic diagram of the time points of animal modeling and samples, in which the model and time points were incorrectly marked. The corrected Figure 3 appears below.

FIGURE 3
www.frontiersin.org

FIGURE 3. CK accelerated the progression of fracture healing. (A) Schematic illustration of time points of animal modeling and sample collection. (B) Representative 3-dimensional micro-CT images of femurs in each group. (C–E) Quantitative analysis of parameters, including CV, BMD, and BV/TV, *p < 0.05, compared with the PBS group, n = 3 (F–G) Biomechanical properties of the fractured bones by 3-point bending test, *p < 0.05, compared with the PBS group, n = 6.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: CK, fracture healing, Wnt/β-catenin, osteogenesis, angiogenesis

Citation: Ding L, Gu S, Zhou B, Wang M, Zhang Y, Wu S, Zou H, Zhao G, Gao Z and Xu L (2022) Corrigendum: Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis. Front. Pharmacol. :952598. doi: 10.3389/fphar.2022.952598

Received: 25 May 2022; Accepted: 30 May 2022;
Published: 16 June 2022.

Edited and reviewed by:

Longhuo Wu, Gannan Medical University, China

Copyright © 2022 Ding, Gu, Zhou, Wang, Zhang, Wu, Zou, Zhao, Gao and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guoping Zhao, Z3B6aGFvQHNpYnMuYWMuY24=; Zhao Gao, cWlxaW4xOTkwQDE2My5jb20=; Liangliang Xu, eHVsbC0yMDE2QGd6dWNtLmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.